Acasti Pharma, Inc. (ACST) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the Acosti Pharma second quarter 2023 earnings event call. All participants will be in listen-only mode. Should you need assistance, please signal conference specialists by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I'd now like to turn the conference over to Robert Bloom with Lithum Partners. Please go ahead. All right. Thank you very much. Welcome to Acosti Pharma's second quarter. fiscal 2023 conference call. On the call with us this afternoon is Jan Del Vies, President and CEO, Brian Ford, Chief Financial Officer, Monique Champagne, VP of Clinical Affairs, and Prashant Kohli, Chief Commercial Officer. Following management's prepared remarks, there will be a Q&A session. Should any questions remain after the call, please contact me at 602- I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information within the meaning of Canadian securities laws and forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and the Securities and Exchange Act of 1934. Such forward-looking statements involve known and unknown risks and uncertainties that could cause the actual results to be materially different from those expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, listeners are urged to consider statements labeled with terms such as belief, expects, intends, anticipates, potential, should, may, will, plans, continue, targeted, or other similar expressions to be uncertain and forward-looking. Listeners...